Novo Nordisk Shares Surge on New Obesity Drug Results
Friday 24th January 2025, 4:52PM
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.
3,006,000 news articles indexed and analysed from 346 sources in 4 languages.
Articles and images are sorted, ranked and categorised automatically, placement is not intended to cause offence.
WireBeat accepts no liability for the content published by third parties.